News Posts List
Treatment & Management of Kidney Cancer
12/13/2018
Treatment for renal cell cancer is tailored to each individual and may include surgery, precision cancer medicines, immunotherapy and chemotherapy. Radiation therapy is not typically used for the treatment of renal cell cancer. The specific treatment depends on the stage and genomic profile of the cancer.
Overview of Renal Cell Cancer
12/13/2018
Symptoms, risk factors and diagnosis of Kidney (Renal Cell) Cancer.
Tivozanib Promising for Metastatic Renal Cell Carcinoma
12/13/2018
Updated clinical trial results reveal Tivozanib superior to Nexavar and headed to the FDA for US approval.
Keytruda- Inlyta Treatment Combination Improves Outcomes in Renal Cell Caner
12/13/2018
The pivotal Phase 3 KEYNOTE-426 clinical trial investigating Keytruda (pembrolizumab) anti-PD-1 therapy in combination with Inlyta (axitinib), a tyrosine kinase inhibitor (TKI) improved both overall survival (OS) and delayed the time to cancer progression compared to Sutent (sunitinib) when used in the first-line treatment of advanced or metastatic renal cell carcinoma (RCC).
Treatment of Stages I - III Kidney Cancer
12/13/2018
Patients with Stage I renal cell cancer have a primary cancer that is less than 7 centimeters in size (about 3 inches). The cancer is limited to the kidney, and has not spread to lymph nodes or distant sites.
Treatment of Stage IV Kidney Cancer
12/13/2018
Patients with Stage IV renal cell cancer have cancer that has spread to distant sites in the body, invaded directly into local structures, or has spread to more than one lymph node. Stage IV disease is also known as metastatic cancer.
Cancer Deaths on the Decline
12/13/2018
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute.
Check Your Medical Records For Dangerous Errors
12/12/2018
This article explains the importance of checking your medical records for mistakes.
A Novel Approach: TKI/I-O Combinations in RCC
12/11/2018
Insights From: Brian Rini,MD, Cleveland Clinic Main Campus; David F. McDermott, MD, Harvard Cancer Center
News Feed